About Serum Institute of India
Serum Institute of India is a company based in Pune (India) founded in 1966 by Villoo Poonawalla and Zavareh Soli Poonawalla.. The company has 7,370 employees as of March 06, 2025. Serum Institute of India has completed 2 acquisitions, including Bilthoven Biologicals and VPM. Serum Institute of India offers products and services including COVISHIELD, Measles Vaccine, Mumps Vaccine, Rubella Vaccine, and DTP Vaccine. Serum Institute of India operates in a competitive market with competitors including BeiGene, Vaxcyte, Vir Biotechnology, BioNTech and Biological E, among others.
- Headquarter Pune, India
- Employees 7370 as on 06 Mar, 2025
- Founders Villoo Poonawalla, Zavareh Soli Poonawalla
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Serum Institute Of India Pvt. Ltd.
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$1.29 B (USD)3.2as on Mar 31, 2024
-
Net Profit
$499.77 M (USD)2.17as on Mar 31, 2024
-
EBITDA
$527.57 M (USD)-19.79as on Mar 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
7370
as on Mar 06, 2025
-
Investments & Acquisitions
Bilthoven Biologicals
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Serum Institute of India
Serum Institute of India offers a comprehensive portfolio of products and services, including COVISHIELD, Measles Vaccine, Mumps Vaccine, Rubella Vaccine, and DTP Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccine for COVID-19 prevention and immune response.
Vaccine to prevent measles infection in children.
Vaccine for protection against mumps virus.
Vaccine to prevent rubella and its complications.
Vaccine against diphtheria, tetanus, and pertussis diseases.
Vaccine for hepatitis prevention and liver protection.
Vaccine to guard against seasonal influenza strains.
Unlock access to complete
Funding Insights of Serum Institute of India
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2012 | Amount | Grant - Serum Institute of India | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Serum Institute of India
Serum Institute of India has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Department of Biotechnology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Serum Institute of India
Serum Institute of India has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bilthoven Biologicals and VPM. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Large scale vaccines manufacturer for infectious diseases, such as polio and tetanus
|
2012 | ||||
|
Consulting, regulatory, and quality management services are provided to biopharma.
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Serum Institute of India
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Serum Institute Of India Comparisons
Competitors of Serum Institute of India
Serum Institute of India operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Vaxcyte, Vir Biotechnology, BioNTech and Biological E, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Serum Institute Of India
Frequently Asked Questions about Serum Institute of India
When was Serum Institute of India founded?
Serum Institute of India was founded in 1966 and raised its 1st funding round 46 years after it was founded.
Where is Serum Institute of India located?
Serum Institute of India is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
How many employees does Serum Institute of India have?
As of Mar 06, 2025, the latest employee count at Serum Institute of India is 7,370.
What is the annual revenue of Serum Institute of India?
Annual revenue of Serum Institute of India is $1.29B as on Mar 31, 2024.
What does Serum Institute of India do?
The company was founded in 1966 in Pune, India, and operates within the pharmaceutical sector. Vaccines for infectious diseases such as tetanus toxoid, diphtheria, measles, mumps, rubella, COVID-19, and hepatitis B are produced, along with other immuno-biological drugs. Manufacturing activities focus on addressing global health needs through these products, with operations centered in India.
Who are the top competitors of Serum Institute of India?
What products or services does Serum Institute of India offer?
Serum Institute of India offers COVISHIELD, Measles Vaccine, Mumps Vaccine, Rubella Vaccine, and 3 more products and services.
How many acquisitions has Serum Institute of India made?
Serum Institute of India has made 2 acquisitions, including Bilthoven Biologicals, and VPM.
Who are Serum Institute of India's investors?
Serum Institute of India has 1 investor. Key investors include Department of Biotechnology.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.